Literature DB >> 26763599

Acute severe male hypo-testosteronemia affects central motor command in humans.

Francesco Felici1, Ilenia Bazzucchi2, Paolo Sgrò2, Federico Quinzi2, Alessandra Conti2, Antonio Aversa3, Leonardo Gizzi4, Marco Mezzullo5, Francesco Romanelli3, Renato Pasquali5, Andrea Lenzi3, Luigi Di Luigi2.   

Abstract

PURPOSE: To indirectly evaluate the effect of androgens on neuromuscular system in humans we analyzed if an induced short-term hypogonadal state (serum total testosterone-TT<2.3ng/ml) may affect central drive to skeletal muscle and/or muscle neuro-mechanical performance.
METHODS: We compared voluntary and electrically evoked muscle sEMG signals from biceps brachii in nine hypogonadal male volunteers (Hypo) and in ten healthy controls (Cont). Serum TT and dihydrotestosterone (DHT) were assayed.
RESULTS: With respect to Hypo, Cont exhibited significantly higher median frequency content (MDF) at any angular velocity; normalized MDF [95.9% (SD=23.3) vs 73.8% (SD=9.3)]; muscle fiber conduction velocity (CV) from lowest to highest angular velocities; initial MDF at fatigue test [91.78Hz (SD=22.03) vs 70.94Hz (SD=11.06)] as well as was the normalized slope [-0.64 (SD=0.14 vs -0.5 (SD=0.11)]. In the non-fatigued state, Hypo showed a slower single twitches time to peak (TTP). In Cont, half relaxation time (HRT) decreased after fatigue while increased in Hypo (p<0.05 between groups). A significant correlation between both TT and dihydrotestosterone with MDF and CV was found during voluntary contractions only.
CONCLUSIONS: A brief exposure to very low serum TT concentration in males seem to determine a reduced excitability of the NM system which, in turn, would favor a predominant recruitment of slow twitch MUs.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Male hypogonadism; Muscle fibers conduction velocity; Neural control; Surface electromyography; Testosterone

Mesh:

Substances:

Year:  2015        PMID: 26763599     DOI: 10.1016/j.jelekin.2015.12.004

Source DB:  PubMed          Journal:  J Electromyogr Kinesiol        ISSN: 1050-6411            Impact factor:   2.368


  6 in total

1.  Dihydrotestosterone (DHT) rapidly increase after maximal aerobic exercise in healthy males: the lowering effect of phosphodiesterase's type 5 inhibitors on DHT response to exercise-related stress.

Authors:  P Sgrò; C Minganti; M Lista; C Antinozzi; M Cappa; Y Pitsiladis; F Pigozzi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2020-09-18       Impact factor: 4.256

Review 2.  Sport and male sexuality.

Authors:  P Sgrò; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-03-22       Impact factor: 4.256

3.  Hydrogen Peroxide Stimulates Dihydrotestosterone Release in C2C12 Myotubes: A New Perspective for Exercise-Related Muscle Steroidogenesis?

Authors:  Cristina Antinozzi; Guglielmo Duranti; Roberta Ceci; Marco Lista; Stefania Sabatini; Daniela Caporossi; Luigi Di Luigi; Paolo Sgrò; Ivan Dimauro
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

Review 4.  Male and female sexual dysfunction in diabetic subjects: Focus on new antihyperglycemic drugs.

Authors:  Giovanni Corona; Andrea M Isidori; Antonio Aversa; Marco Bonomi; Alberto Ferlin; Carlo Foresta; Sandro La Vignera; Mario Maggi; Rosario Pivonello; Linda Vignozzi; Francesco Lombardo
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

5.  Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells.

Authors:  C Antinozzi; F Marampon; C Corinaldesi; E Vicini; P Sgrò; G B Vannelli; A Lenzi; C Crescioli; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-05-15       Impact factor: 4.256

6.  Quercetin Supplementation Improves Neuromuscular Function Recovery from Muscle Damage.

Authors:  Ilenia Bazzucchi; Federica Patrizio; Roberta Ceci; Guglielmo Duranti; Stefania Sabatini; Paolo Sgrò; Luigi Di Luigi; Massimo Sacchetti
Journal:  Nutrients       Date:  2020-09-17       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.